Search Results - Appelt, M.D.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Avaliação de probiótico na alimentação de poedeiras comerciais no segundo ciclo de postura

    Avaliação de probiótico na alimentação de poedeiras comerciais no segundo ciclo de postura by Nunes, R.V., Scherer, C., Silva, W.T.M., Appelt, M.D., Pozza, P.C., Vieites, F.M.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Avaliação de probiótico na alimentação de poedeiras comerciais no segundo ciclo de postura

    Avaliação de probiótico na alimentação de poedeiras comerciais no segundo ciclo de postura by Nunes, R.V., Scherer, C., Silva, W.T.M., Appelt, M.D., Pozza, P.C., Vieites, F.M.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Avaliação de probiótico na alimentação de poedeiras comerciais no segundo ciclo de postura Evaluation of probiotics in feed for laying hens in the second cycle stance

    Avaliação de probiótico na alimentação de poedeiras comerciais no segundo ciclo de postura Evaluation of probiotics in feed for laying hens in the second cycle stance by R.V. Nunes, C. Scherer, W.T.M. Silva, M.D. Appelt, P.C. Pozza, F.M. Vieites

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PO-1831 Heterogeneously Hypo-fractionated RT for LA-NSCLC (the HERAN trial): Clinical treatment plan results

    PO-1831 Heterogeneously Hypo-fractionated RT for LA-NSCLC (the HERAN trial): Clinical treatment plan results by Hoffmann, L., Appelt, A., Knap, M.M., Møller, D.S., Hansen, T.S., Christiansen, C., Lund, M.D., Nielsen, M., Nielsen, T.B., Schytte, T., Thing, R., Khali, A.A.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PD-0268: Using systematic CTC registration in the clinic to aid competent care of acute side-effects of radiotherapy

    PD-0268: Using systematic CTC registration in the clinic to aid competent care of acute side-effects of radiotherapy by Olling, K, Holberg, L, Hansen, M, Lund, M.D, Appelt, A.L

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2

    EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2 by Nielsen, T.B, Brink, C, Moeller, D.S, Hoffmann, L, Lutz, C.M, Appelt, A.L, Lund, M.D, Nielsen, M.S, Ottosson, W, Khalil, A.A, Knap, M.M, Hansen, O, Schytte, T

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial

    OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial by Moeller, D.S, Hoffmann, L, Lutz, C.M, Nielsen, T.B, Brink, C, Appelt, A.L, Lund, M.D, Nielsen, M.S, Ottosson, W, Khalil, A.A, Knap, M.M, Hansen, O, Schytte, T

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    EP-1352 Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor

    EP-1352 Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor by Persson, G., Schytte, T., Appelt, A.L., Borissova, S., Brink, C., Hansen, T.S., Hoffmann, L., Josipovic, M., Khalil, A.A., Knap, M.M., Lund, M.D., Lutz, C.M., Møller, D.S., Nielsen, T.B., Nielsen, M., Ottosson, W., Pøhl, M., Thomsen, J.B., Hansen, O.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: